Lv0
0 积分 2023-10-22 加入
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
22小时前
已完结
ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation
10个月前
已完结
Outcomes for Hyperthermia Combined with Concurrent Radiochemotherapy for Patients with Cervical Cancer
1年前
已完结
Microglia drive transient insult-induced brain injury by chemotactic recruitment of CD8+ T lymphocytes
1年前
已完结
Microglia drive transient insult-induced brain injury by chemotactic recruitment of CD8+ T lymphocytes
1年前
已完结
皖公网安备34019202002308
